Company intelligence / Profile preview

Laureus

Hamburg, Hamburg, Germanylaureus.com ↗

Ownership: Private
Development stage: Other

Overview

Laureus Capital GmbH is a German investment firm focused on technology, artificial intelligence, and biotechnology. It actively invests in innovative life sciences companies such as Ethris—a Munich-based biotech developing messenger RNA therapeutics for diseases caused by missing or defective proteins. The firm was founded by Christian Wawrzinek and Kai Wawrzinek.

Therapeutic areas: Rare Diseases
Modalities: mRNA-based drugs
Industry: Investors

Partnerships

Partnership with Ethris management team post-investment

Beyond the preview

Go deeper on Laureus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laureus.

Explore the full profile